pharmaceuticals
Novo Nordisk Cuts Wegovy Price in South Africa for a Second Time
Analysis-TrumpRx Lists Many Medicines at Prices Higher Than Paid in UK
Roche Ramps up AI Computing Capacity With Nvidia Chip Expansion
FinanceBrazil Drugmaker Ems Eyes Overseas Deals After Buying Sanofi Unit
Novo Nordisk Strikes Deal for Hims to Sell Wegovy and Ozempic, Drops Lawsuit
Date: March 9, 2026
COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday,...
Roche Shares Drop as Oral Breast Cancer Drug Fails in Trial
Date: March 9, 2026
FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candidate giredestrant against a common form of breast...
Gsk Licenses Liver Disease Drug to Italy's Alfasigma for up to $690 Million
Date: March 9, 2026
March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to linerixibat, an experimental treatment for severe...
Galderma Gives Better Than Expected 2026 Guidance, Shares Rise
Date: March 5, 2026
March 5 (Reuters) - Shares of Swiss skincare company Galderma opened higher on Thursday after it reported 17.7% growth in full-year net sales and gave an upbeat guidance for 2026. The annual net...
Sino Biopharm Unit Licenses Blood Cancer Drug to Sanofi for up to $1.53 Billion
Date: March 3, 2026
March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an exclusive global licensing deal with French drugmaker Sanofi worth up to $1.53 billion, giving the...
Hims' Pharmacy Partner Will Reintroduce GLP-1 Pill Pulled From Market, Endpoints News Reports
Date: March 3, 2026
March 3 (Reuters) - Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of its compounded weight‑loss pill through other healthcare providers after halting distribution...
